• Something wrong with this record ?

Hereditary xanthinuria is not so rare disorder of purine metabolism

I. Sebesta, B. Stiburkova, J. Krijt,

. 2018 ; 37 (6) : 324-328. [pub] 20180503

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc19028448

Hereditary xanthinuria (type I) is caused by an inherited deficiency of the xanthine oxidorectase (XDH/XO), and is characterized by very low concentration of uric acid in blood and urine and high concentration of urinary xanthine, leading to urolithiasis. Type II results from a combined deficiency of XDH/XO and aldehyde oxidase. Patients present with hematuria, renal colic, urolithiasis or even acute renal failure. Clinical symptoms are the same for both types. In a third type, clinically distinct, sulfite oxidase activity is missing as well as XDH/XO and aldehyde oxidase. The prevalence is not known, but about 150 cases have been described so far. Hypouricemia is sometimes overlooked, that´s why we have set up the diagnostic flowchart. This consists of a) evaluation of uric acid concentrations in serum and urine with exclusion of primary renal hypouricemia, b) estimation of urinary xanthine, c) allopurinol loading test, which enables to distinguish type I and II; and finally assay of xanthine oxidoreductase activity in plasma with molecular genetic analysis. Following this diagnostic procedure we were able to find first patients with hereditary xanthinuria in our Czech population. We have detected nine cases, which is one of the largest group worldwide. Four patients were asymptomatic. All had profound hypouricemia, which was the first sign and led to referral to our department. Urinary concentrations of xanthine were in the range of 170-598 mmol/mol creatinine (normal < 30 mmol/mol creatinine). Hereditary xanthinuria is still unrecognized disorder and subjects with unexplained hypouricemia need detailed purine metabolic investigation.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028448
003      
CZ-PrNML
005      
20190823103223.0
007      
ta
008      
190813s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1080/15257770.2018.1460478 $2 doi
035    __
$a (PubMed)29723117
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Sebesta, I $u a Institute of Inherited Metabolic Disorders, First Faculty of Medicine , Charles University , Prague , Czech Republic. b Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine , Charles University , Prague , Czech Republic.
245    10
$a Hereditary xanthinuria is not so rare disorder of purine metabolism / $c I. Sebesta, B. Stiburkova, J. Krijt,
520    9_
$a Hereditary xanthinuria (type I) is caused by an inherited deficiency of the xanthine oxidorectase (XDH/XO), and is characterized by very low concentration of uric acid in blood and urine and high concentration of urinary xanthine, leading to urolithiasis. Type II results from a combined deficiency of XDH/XO and aldehyde oxidase. Patients present with hematuria, renal colic, urolithiasis or even acute renal failure. Clinical symptoms are the same for both types. In a third type, clinically distinct, sulfite oxidase activity is missing as well as XDH/XO and aldehyde oxidase. The prevalence is not known, but about 150 cases have been described so far. Hypouricemia is sometimes overlooked, that´s why we have set up the diagnostic flowchart. This consists of a) evaluation of uric acid concentrations in serum and urine with exclusion of primary renal hypouricemia, b) estimation of urinary xanthine, c) allopurinol loading test, which enables to distinguish type I and II; and finally assay of xanthine oxidoreductase activity in plasma with molecular genetic analysis. Following this diagnostic procedure we were able to find first patients with hereditary xanthinuria in our Czech population. We have detected nine cases, which is one of the largest group worldwide. Four patients were asymptomatic. All had profound hypouricemia, which was the first sign and led to referral to our department. Urinary concentrations of xanthine were in the range of 170-598 mmol/mol creatinine (normal < 30 mmol/mol creatinine). Hereditary xanthinuria is still unrecognized disorder and subjects with unexplained hypouricemia need detailed purine metabolic investigation.
650    _2
$a dospělí $7 D000328
650    _2
$a aldehydoxidasa $x krev $x nedostatek $x moč $7 D042931
650    _2
$a alopurinol $x metabolismus $7 D000493
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a diferenciální diagnóza $7 D003937
650    _2
$a lidé $7 D006801
650    _2
$a vrozené poruchy metabolismu $x krev $x diagnóza $x epidemiologie $x moč $7 D008661
650    _2
$a poruchy metabolismu purinů a pyrimidinů $x krev $x diagnóza $x epidemiologie $x moč $7 D011686
650    _2
$a puriny $x metabolismus $7 D011687
650    _2
$a vrozené poruchy tubulárního transportu $x krev $x epidemiologie $x moč $7 D015499
650    _2
$a kyselina močová $x krev $x moč $7 D014527
650    _2
$a močové kameny $x krev $x epidemiologie $x moč $7 D014545
650    _2
$a xanthin $x krev $x moč $7 D019820
650    _2
$a xanthindehydrogenasa $x krev $x nedostatek $x metabolismus $x moč $7 D014968
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Stiburkova, B $u a Institute of Inherited Metabolic Disorders, First Faculty of Medicine , Charles University , Prague , Czech Republic. c Institute of Rheumatology, First Faculty of Medicine , Charles University , Prague , Czech Republic.
700    1_
$a Krijt, J $u a Institute of Inherited Metabolic Disorders, First Faculty of Medicine , Charles University , Prague , Czech Republic.
773    0_
$w MED00008893 $t Nucleosides, nucleotides & nucleic acids $x 1532-2335 $g Roč. 37, č. 6 (2018), s. 324-328
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29723117 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190823103437 $b ABA008
999    __
$a ok $b bmc $g 1433597 $s 1066908
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 37 $c 6 $d 324-328 $e 20180503 $i 1532-2335 $m Nucleosides, nucleotides & nucleic acids $n Nucleosides Nucleotides Nucleic Acids $x MED00008893
LZP    __
$a Pubmed-20190813

Find record

Citation metrics

Archiving options